Follicular lymphomas--a review of treatment modalities.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Critical reviews in oncology/hematology

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1040-8428(00)00066-4PMID 10863149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I‐II non‐hodgkin's lymphomas

  2006influential reference
• Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group.

  1999cited by this paper
• Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.

  1999cited by this paper
• Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

  1999cited by this paper
• Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma

  1999cited by this paper
• Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas

  1999cited by this paper
• Competitive polymerase chain reaction to quantify tumor cells in peripheral blood of patients with T(14;18)‐bearing follicular non‐Hodgkin's lymphoma: An exploratory study in 8 patients

  1999cited by this paper
• Quality of life in patients with low-grade non-Hodgkin's lymphoma.

  1998cited by this paper
• Cladribine for untreated or early low-grade non-Hodgkin's lymphoma.

  1998cited by this paper
• Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.

  1998cited by this paper
• New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.

  1998cited by this paper
• Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma.

  1998cited by this paper
• Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.

  1998cited by this paper
• [Evaluation of the quality of life in clinical research in cancerology].

  1998cited by this paper
• Morphologic, Immunophenotypic, and Molecular Evaluation of Bone Marrow Involvement in Non‐Hodgkin's Lymphoma

  1998cited by this paper
• Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: results of a pilot study.

  1998cited by this paper
• Allogeneic bone marrow transplantation with T‐cell‐depleted marrow grafts for patients with poor‐risk relapsed low‐grade non‐Hodgkin's lymphoma

  1998cited by this paper
• Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

  1998cited by this paper
• Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

  1998cited by this paper
• [Dose-effects and chemotherapy dose intensity of aggressive non-Hodgkin's lymphomas in the adult].

  1998cited by this paper
• Relationships between dose or dose intensity and efficacy of chemotherapy in adult aggressive non-Hodgkin’s lymphomas

  1998cited by this paper
• The clinical significance of molecular response in indolent follicular lymphomas.

  1998cited by this paper
• Efficacy and toxicity of 2-Chlorodeoxyadenosine (Cladribine)--2 h infusion for 5 days--as first-line treatment for advanced low grade non-Hodgkin's lymphoma.

  1998cited by this paper
• Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.

  1998cited by this paper
• Effets-dose et intensité de dose des chimiothérapies des lymphomes non hodgkiniens agressifs de l’adulte

  1998cited by this paper
• Iodine-131 anti-B1 antibody for B-cell lymphoma: an update on the Michigan Phase I experience.

  1998cited by this paper
• From the R.E.A.L. Classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities?

  1998cited by this paper
• Detection of lymphoma in bone marrow by whole-body positron emission tomography.

  1998cited by this paper
• 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.

  1998cited by this paper
• Allogeneic bone marrow transplantation for low-grade lymphoma.

  1998cited by this paper
• Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making.

  1998cited by this paper
• Evaluation de la qualité de vie dans la recherche clinique en cancérologie

  1998cited by this paper
• Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization.

  1998cited by this paper
• Reporting on quality of life in randomised controlled trials: bibliographic study

  1998cited by this paper
• Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.

  1998cited by this paper
• Chapter 19 - Follicular lymphoma

  1998cited by this paper
• Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphoma.

  1997cited by this paper
• Follicular lymphoma: grounds for optimism.

  1997cited by this paper
• Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma.

  1997cited by this paper
• Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma.

  1997cited by this paper
• Magnetic resonance imaging of the bone marrow in hematologic malignancies.

  1997cited by this paper
• Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.

  1997cited by this paper
• Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.

  1997cited by this paper
• A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.

  1997influential reference
• Revisiting the prognostic role of gallium scintigraphy in low-grade Non-Hodgkin’s lymphoma

  1997cited by this paper
• Cure and follicular lymphoma.

  1997cited by this paper
• IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.

  1997cited by this paper
• 2-Chlorodeoxyadenosine as initial therapy for advanced low grade lymphomas.

  1997cited by this paper
• Cancer-specific quality of life questionnaires: the state of the art in Europe.

  1997cited by this paper
• Is comprehensive lymphatic irradiation for low-grade non-Hodgkin's lymphoma curative therapy? Long-term experience at a single institution.

  1997cited by this paper
• Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

  1997influential reference
• Euthanasia and physician-assisted suicide: a comparative survey of physicians, terminally ill cancer patients, and the general population.

  1997cited by this paper
• BCL-2 antisense therapy in patients with non-Hodgkin lymphoma.

  1997cited by this paper
• Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.

  1997cited by this paper
• Do oncologists have an increasing interest in the quality of life of their patients? A literature review of the last 15 years.

  1997cited by this paper
• Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas.

  1997cited by this paper
• Introduction to the WHO Classification

  1997cited by this paper
• Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma.

  1997cited by this paper
• Clinical relevance of bcl-2(MBR)/J(H) rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphoma.

  1997cited by this paper
• Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.

  1996cited by this paper
• Is there any place for a wait-and-see policy in stage I0 follicular lymphoma? A study of 43 consecutive patients in a single center.

  1996cited by this paper
• 2-Chlorodeoxyadenosine treatment in non-Hodgkin's Lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy: results of a multicentric experience

  1996cited by this paper
• Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system

  1996cited by this paper
• Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma.

  1996cited by this paper
• 2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma.

  1996cited by this paper
• Interferon alpha 2b as maintenance therapy in low grade malignant lymphoma improves duration of remission and survival.

  1996cited by this paper
• The follicular non-Hodgkin's lymphomas--II. Prognostic factors: what do they mean?

  1996cited by this paper
• Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation.

  1996cited by this paper
• The follicular non-Hodgkin's lymphomas--I. The possibility of cure.

  1996cited by this paper
• Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival.

  1996cited by this paper
• The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30

  1996cited by this paper
• Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.

  1996influential reference
• Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.

  1996influential reference
• High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.

  1996cited by this paper
• The cell death inhibitor Bcl‐2 and its homologues influence control of cell cycle entry.

  1996cited by this paper
• Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death

  1996cited by this paper
• High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma.

  1996cited by this paper
• Trial-related quality of life: using quality-of-life assessment to distinguish among cancer therapies.

  1996cited by this paper
• Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.

  1996cited by this paper
• Bone Marrow Biopsy for the Staging of Non-Hodgkin's Lymphoma: Bilateral or Unilateral Trephine Biopsy?

  1995cited by this paper
• Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.

  1995cited by this paper
• Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma

  1995cited by this paper
• Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

  1995cited by this paper
• Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates.

  1995cited by this paper
• Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center.

  1995cited by this paper
• Autologous bone marrow transplantation as consolidation therapy may prolong remission in newly diagnosed high-risk follicular lymphoma: a pilot study of 34 cases.

  1995cited by this paper
• FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low‐grade non‐Hodgkin's lymphoma

  1995cited by this paper
• Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma.

  1994cited by this paper
• Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.

  1994cited by this paper
• Clinical significance of t(14; 18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission.

  1994cited by this paper
• Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. EBMT Working Party for Lymphoma.

  1994cited by this paper
• Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients.

  1994cited by this paper
• New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only--a preliminary update of the German Low-Grade Lymphoma Study Group.

  1994cited by this paper
• Treatment approaches to the low-grade lymphomas.

  1994cited by this paper
• Fludarabine in lymphoproliferative disorders: the Royal Marsden Hospital experience.

  1994cited by this paper
• Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.

  1994influential reference
• Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central Sweden.

  1994cited by this paper
• A British national lymphoma investigation randomised trial of single agent chlorambucil plus radiotherapyversus radiotherapy alone in low grade, localised non-hodgkins Lymphoma

  1994influential reference
• What does BCL-2 mean in solid tumours--friend or foe?

  1994cited by this paper
• Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma.

  1994cited by this paper

• Incidental Lymphoma Discovered During Surveillance for Low-Grade Upper Tract Urothelial Carcinoma Treated Ureteroscopically: A Case Report Series

  2016cites this paper
• Allogene hämatopoetische Stammzelltransplantation bei Patienten mit Follikulärem Lymphom

  2015cites this paper
• [Non-hodgkin's lymphomas].

  2010cites this paper
• Lymphomes malins non hodgkiniens Non-hodgkin ’ s lymphomas

  2010cites this paper
• Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma.

  2005cites this paper
• Fludarabine phosphate-CVP in patients over 60 years of age with advanced, low-grade and follicular lymphoma: a dose-finding study.

  2005cites this paper
• Interferon Alpha 2b as Maintenance Therapy Improves Outcome In Follicular Lymphoma

  2004cites this paper
• Pharmacokinetics of Biologicals

  2004cites this paper
• Efficiency of in vivo purging with autologous stem cell transplantation and monoclonal antibody in B-cell lymphomas.

  2003cites this paper
• [Follicle centre lymphoma: treatment results for stage I and II].

  2003cites this paper
• Behandlungsergebnisse beim follikulären Keimzentrumslymphom Stadium I und II

  2003influential citation
• [Update on lymphomas].

  2002cites this paper
• Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma.

  2001cites this paper
• Radiation therapy for stage III follicular lymphoma-often ignored, but still effective.

  2001cites this paper
• Synthetic Phosphoantigens Enhance Human Vγ9Vδ2 T Lymphocytes Killing of Non-Hodgkin’s B Lymphoma

  2001cites this paper
• Detection of bcl-2/IgH Rearrangements by Quantitative-competitive PCR and Capillary Electrophoresis

  2001cites this paper
• Recent publications in hematological oncology.

  2001cites this paper
• 3. Report on Workshop: UICC Workshop “Therapy of NHL in early stages”

  2001cites this paper